Akari Therapeutics Plc (AKTX) Balance Sheet
As of 2026-06-30 (10-Q), Akari Therapeutics Plc (AKTX) reported total assets of $38.6M, total liabilities of $20.0M and shareholders' equity of $18.6M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $7.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AKTXAkari Therapeutics PlcFollow AKTX — free
—
Price chart with a free account
- Market cap
- 640.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Mar 19 | FY2019 Jun 19 | FY2019 Sep 19 | FY2019 Dec 19 | FY2020 Mar 20 | FY2020 Jun 20 | FY2020 Sep 20 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.0 | 1.1 | 0.6 | 3.3 | 68.9 | 34.1 | 28.1 | 5.4 | 6.1 | 2.7 | 6.3 | 5.7 | 7.8 | 12.7 | 12.3 | 14.1 | 9.4 | 13.3 | 3.8 | 2.7 | 5.3 | 7.8 | |
| Short-term investments | — | — | — | — | 0.0 | 10.0 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current assets | 0.0 | 1.1 | 7.8 | 3.3 | 69.7 | 45.6 | 28.8 | 7.5 | 8.0 | 4.6 | 10.2 | 6.4 | 9.7 | 14.4 | 13.7 | 14.6 | 11.6 | 13.8 | 4.3 | 3.0 | 5.5 | 8.3 | |
| Total assets | 0.0 | 1.1 | 7.8 | 3.4 | 69.9 | 45.9 | 29.1 | 8.0 | 8.2 | 4.6 | 10.3 | 6.5 | 9.7 | 14.5 | 13.7 | 14.6 | 11.6 | 13.8 | 4.4 | 50.6 | 47.9 | 38.6 | |
| Current liabilities | 2.2 | 3.9 | 1.2 | 1.2 | 21.1 | 11.7 | 11.8 | 4.9 | — | — | — | — | — | — | — | — | — | — | 4.6 | 19.9 | 12.4 | 13.9 | |
| Short-term debt | 0.0 | 0.9 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Total liabilities | — | — | — | 1.2 | 21.2 | 11.8 | 11.9 | 4.9 | 3.4 | 4.2 | 5.4 | 6.5 | 6.4 | 8.5 | 6.7 | 5.2 | 6.1 | 12.0 | 4.6 | 28.3 | 19.6 | 20.0 | |
| Shareholders' equity | -2.5 | -3.4 | 0.4 | 2.2 | 48.7 | 34.1 | 22.2 | 4.4 | 4.8 | 0.5 | 4.9 | 0.0 | 3.3 | 6.0 | 6.9 | 9.4 | 5.6 | 1.8 | -0.2 | 22.2 | 28.3 | 18.6 |
USD millions · SEC XBRL
Akari Therapeutics Plc — questions
- How much cash does Akari Therapeutics Plc have?
- $7.8M in cash and cash equivalents as of 2026-06-30.
- What are Akari Therapeutics Plc's total assets?
- $38.6M as of 2026-06-30.
- What is Akari Therapeutics Plc's shareholders' equity?
- $18.6M as of 2026-06-30.
Every figure on this page comes from Akari Therapeutics Plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.